Sacked drug safety manager accused of false allegations A sacked drug safety manager at Roche has been accused of making "false" allegations about his former colleagues to the Workplace Relations Commission by lawyers … Business • 24 Feb
Drug safety manager alleges 'cover-up' at Roche A drug safety manager at international pharma giant Roche has alleged before the Workplace Relations Commission that there was widespread non-compliance in marketing materials distributed … Business • 23 Feb
Roche warns drug pricing agreement will curtail revenue A new drugs pricing agreement with the Department of Health and the HSE will further curtail revenue growth at the Irish arm of pharma giant … Business • 16 Jan
Roche sales decline more than expected Roche's quarterly sales declined 6% as a slump in Covid-19 treatments and diagnostic testing outweighed gains from haemophilia treatment Hemlibra and multiple sclerosis drug Ocrevus. Business • 18 Oct 22
Roche first quarter sales up 10%, confirms 2022 outlook Swiss drugmaker Roche's first quarter sales rose a better-than-expected 10% on strong US demand for rapid Covid-19 antigen tests and drugs including Ocrevus against multiple … Business • 25 Apr 22
Roche sees slower 2022 sales growth Swiss drugmaker Roche said that sales growth would slow this year as it braces for less demand for its Covid-19 medicines and tests, expecting immunity … Business • 03 Feb 22
Roche ups outlook as Delta variant spurs test demand Swiss drugmaker Roche has raised its 2021 sales forecast after posting an 8% rise in nine-month revenues, powered by demand for Covid-19 tests and strength … Business • 20 Oct 21
Roche Ireland recorded pre-tax loss of €35.5m in 2020 Costs associated with the shutdown and decommissioning of Roche's only Irish manufacturing plant at Clarecastle in Co Clare contributed to pre-tax losses soaring to €35.5m … Business • 18 Aug 21
Roche sales rebound as Covid-19 tests help power growth Roche's first-half net profit rose 2% to 8.22 billion Swiss francs ($8.96 billion) and sales increased by 8% at constant exchange rates to a better-than … Business • 22 Jul 21
Covid tests offset falling drugs sales at Roche Swiss drugmaker Roche is sticking to its 2021 forecast for revenue growth, as first-quarter sales of Covid-19 tests offset a slumping main drug business that … Business • 21 Apr 21
Irish arm of Roche continues to trade profitably The main Irish arm of pharma giant, Roche overcame the challenges posed by Covid-19 and continued to trade profitably during 2020. Business • 09 Apr 21
Roche's Q4 sales helped by Covid-19 test business Swiss drugmaker Roche got a fourth-quarter lift from its Covid-19 test business, where higher sales offset a decline at its drugs unit whose revenue was … Business • 04 Feb 21
Roche confirms 2020 outlook as Covid diagnostics surge The frantic global effort to test people for Covid-19 pushed Roche's diagnostics division to record revenue, helping the Swiss drugmaker offset declining drug sales and … Business • 15 Oct 20
Offaly-based PPE provider reports rapid growth Critical Healthcare, a provider of frontline medical products including PPE, has reported rapid growth as a result of the Covid-19 pandemic. Business • 02 Oct 20
Biotech firm Inflazome bought by Roche for €380m Irish biotech company Inflazome has been acquired by Swiss multinational healthcare company Roche for €380m. Business • 21 Sep 20
New Roche coronavirus test wins emergency US approval The US Food and Drug Administration (FDA) has issued emergency authorisation for a faster coronavirus test made by Swiss diagnostics maker Roche. Business • 02 Sep 21
Germany advises drug makers to examine supply chain German drug makers have been asked by the government to examine their supply chains for any vulnerability that could cause shortages of essential drugs in … Business • 29 Aug 18
Roche to buy US cancer drugmaker Ignyta for $1.7bn Swiss drugmaker Roche will buy US cancer drugmaker Ignyta for $1.7 billion to broaden its oncology portfolio globally, the companies said today. Business • 22 Dec 17
Minister criticised over Roche job losses Minister for Jobs, Enterprise and Innovation Mary Mitchell O'Connor has been criticised by a party colleague for not doing enough to save the 240 jobs … News • 05 Jul 16
Efforts to save 240 jobs in Clare unsuccessful The Roche pharmaceutical plant in Clarecastle, Co Clare has confirmed that negotiations to buy its facility in the town and save some of the 240 … Business • 17 May 16
Roche to buy majority stake in Foundation Roche Holding will acquire a majority stake in molecular and genomic analysis firm Foundation Medicine for up to $1.18 billion, it said today. Business • 12 Jan 15
Double blow for Roche as studies fail Roche is to discontinue a late-stage study of an experimental Alzheimer's drug after it failed to prove effective. Business • 19 Dec 14
Roche to acquire InterMune in $8.3bn deal Roche Holding has agreed to buy US biotech company InterMune for $8.3bn in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector. Business • 25 Aug 14
Roche to pay $725m in cash to buy Seragon Roche has said it will pay $725m in cash to buy Seragon Pharmaceuticals, a privately-held biotech company that researches breast cancer treatments, Business • 02 Jul 14
400 jobs secured at Roche plant in Clare Roche pharmaceutical has announced that it is to continue production at its manufacturing plant in Clarecastle outside Ennis in Co Clare. Business • 27 Jun 12
